Home > Boards > US OTC > Medical - Drugs > Innovation Pharmaceuticals Inc. (IPIX)

Actually, a number of existing drugs have

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
a1derfullife Member Profile
 
Followed By 3
Posts 408
Boards Moderated 1
Alias Born 07/12/05
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 1/15/2021 12:36:13 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/22/2020 9:01:10 AM
Biotech Companies; Recent Milestones and Potential Upside InvestorsHub NewsWire - 12/22/2020 8:05:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 12/10/2020 6:03:50 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/16/2020 12:47:44 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/16/2020 9:01:35 AM
Epazz, Inc. (OTC Pink: EPAZ) Adds Vaccine Management as part of COVID Compliance Features InvestorsHub NewsWire - 11/10/2020 6:48:57 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/2/2020 12:00:54 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/15/2020 10:02:03 AM
Annual Report (10-k) Edgar (US Regulatory) - 9/14/2020 4:51:25 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/4/2020 9:32:58 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/4/2020 9:30:11 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/22/2020 10:01:06 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/20/2020 3:10:16 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 7/20/2020 6:03:30 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 7/15/2020 10:56:17 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 7/10/2020 5:09:32 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 7/10/2020 3:07:19 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/19/2020 5:28:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/26/2020 2:16:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/21/2020 9:33:35 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/14/2020 9:03:05 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/28/2020 9:30:58 AM
Cannabis and CBD Stocks are Old News, The Next Hot Peripheral Sector is Here! InvestorsHub NewsWire - 4/16/2020 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/6/2020 2:21:58 PM
a1derfullife   Friday, 01/04/13 03:48:46 PM
Re: petemantx post# 19228
Post # of 341804 
Actually, a number of existing drugs have been shown to be effective on multiple cancers (paclitaxel and avastin are two examples). These drugs have all been approved for one condition, and have later been extended to other conditions after additional studies demonstrating effectiveness on the other conditions were performed. It's unlikely that Kevetrin will be treated any differently. However, even if Kevetrin is just used for lung cancer, it could still generate revenues of several billion dollars/year, just in the US. Other indications would be icing on the cake.

A1

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences